Back to Search
Start Over
Secondary histiocytic sarcoma with BRAFV600E mutation responsive to MAPK‐targeted therapy presenting with recurrence with mTOR mutation responsive to mTOR‐targeted therapy.
- Source :
- Pediatric Blood & Cancer; Oct2021, Vol. 68 Issue 10, p1-3, 3p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 15455009
- Volume :
- 68
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Pediatric Blood & Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 152037578
- Full Text :
- https://doi.org/10.1002/pbc.29166